BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1169 related articles for article (PubMed ID: 15209435)

  • 1. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity risk associated with the K121Q polymorphism of the glycoprotein PC-1 gene.
    Wan C; Zhang T; Wang B; Han Y; Zhang C; Zhang Y; Gong H; Jin F; Wang L
    Diabetes Obes Metab; 2006 Nov; 8(6):703-8. PubMed ID: 17026496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
    Abate N; Chandalia M; Di Paola R; Foster DW; Grundy SM; Trischitta V
    Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):694-701. PubMed ID: 17143316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENPP1 gene, insulin resistance and related clinical outcomes.
    Bacci S; De Cosmo S; Prudente S; Trischitta V
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):403-9. PubMed ID: 17563456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.
    González-Sánchez JL; Zabena C; Martínez-Larrad MT; Martínez-Calatrava MJ; Pérez-Barba M; Serrano-Ríos M
    Clin Endocrinol (Oxf); 2008 May; 68(5):724-9. PubMed ID: 17986276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population.
    González-Sánchez JL; Martínez-Larrad MT; Fernández-Pérez C; Kubaszek A; Laakso M; Serrano-Ríos M
    Obes Res; 2003 May; 11(5):603-5. PubMed ID: 12740448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome in patients with coronary heart disease.
    Tasic I; Milojkovic M; Sunder-Plassmann R; Lazarevic G; Tasic NM; Stefanovic V
    Clin Chim Acta; 2007 Feb; 377(1-2):237-42. PubMed ID: 17129580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction.
    Endler G; Mannhalter C; Sunder-Plassmann H; Schillinger M; Klimesch A; Exner M; Kapiotis S; Meier S; Kunz F; Raiger E; Huber K; Wagner O; Sunder-Plassmann R
    J Mol Med (Berl); 2002 Dec; 80(12):791-5. PubMed ID: 12483464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
    Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo.
    Zhou HH; Chin CN; Wu M; Ni W; Quan S; Liu F; Dallas-Yang Q; Ellsworth K; Ho T; Zhang A; Natasha T; Li J; Chapman K; Strohl W; Li C; Wang IM; Berger J; An Z; Zhang BB; Jiang G
    Eur J Pharmacol; 2009 Aug; 616(1-3):346-52. PubMed ID: 19577557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals.
    Bochenski J; Placha G; Wanic K; Malecki M; Sieradzki J; Warram JH; Krolewski AS
    Diabetes; 2006 Sep; 55(9):2626-30. PubMed ID: 16936213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity.
    Chin CN; Dallas-Yang Q; Liu F; Ho T; Ellsworth K; Fischer P; Natasha T; Ireland C; Lu P; Li C; Wang IM; Strohl W; Berger JP; An Z; Zhang BB; Jiang G
    Eur J Pharmacol; 2009 Mar; 606(1-3):17-24. PubMed ID: 19374858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TNF-alpha PC-1 gene polymorphisms and pre-diabetes quantitative features in the Polish population].
    Wanic K; Małecki M; Klupa T; Witek P; Kozek E; Sieradzki J
    Przegl Lek; 2002; 59(11):888-91. PubMed ID: 12715715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM.
    Shao J; Catalano PM; Yamashita H; Ruyter I; Smith S; Youngren J; Friedman JE
    Diabetes; 2000 Apr; 49(4):603-10. PubMed ID: 10871198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus.
    Maddux BA; Sbraccia P; Kumakura S; Sasson S; Youngren J; Fisher A; Spencer S; Grupe A; Henzel W; Stewart TA
    Nature; 1995 Feb; 373(6513):448-51. PubMed ID: 7830796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary PC-1 and N-acetyl-beta-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide.
    Stefanović V; Antić S; Mitić-Zlatković M; Stojiljković S; Milojković M; Bogicević M; Vlahović P
    Ann Clin Biochem; 2003 May; 40(Pt 3):232-4. PubMed ID: 12803833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary PC-1 activity in patients with type 1 diabetes mellitus.
    Stefanović V; Rajić M; Antić S; Mitić-Zlatković M; Stojiljković S; Ivić MA; Vlahović P
    Ann Clin Biochem; 2003 May; 40(Pt 3):235-8. PubMed ID: 12803834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus.
    Tomazic M; Janez A; Sketelj A; Kocijancic A; Eckel J; Sharma PM
    Diabetologia; 2002 Apr; 45(4):502-8. PubMed ID: 12032625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
    Goldfine ID; Maddux BA; Youngren JF; Reaven G; Accili D; Trischitta V; Vigneri R; Frittitta L
    Endocr Rev; 2008 Feb; 29(1):62-75. PubMed ID: 18199690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.